Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both global 1000 companies and startup ventures. Scott is an industry expert on how enterprises can leverage digital and other emerging technologies to accelerate innovation and new venture creation. He has held executive positions with several Fortune 500 companies and has been a featured thought leader in publications including CIO, WIRED, Forbes, [email protected], Los Angeles Times and The Wall Street Journal. Scott is also the co-author of Goliath’s Revenge, a book focused on how established companies can turn the table through digital disruption.
He earned his B.S., M.S., and Ph.D. in Systems Engineering from the University of Pennsylvania. Scott is currently a Senior Fellow in the Management Department at the Wharton School.
Articles by Scott Snyder
Webinar: Can Omnichannel Deliver the ROI Pharma Needs to Keep Investing?
As advances in technology continue to modify the biopharma industry at an increasingly rapid pace, embracing digital innovation is crucial to generating success in today’s modern landscape. In this webinar hosted by Pharmaceutical Executive, industry experts from multiple organizations discuss how pharmaceutical companies can best utilize omnichannel beyond traditional strategies to create more streamlined and seamless patient experiences in oncology and health care in general. Watch to learn more about how adopting digital solutions can transform the path to treatment for both HCPs and patients and launch brands out of outdated processes and into elevated levels of marketability and customer satisfaction to meet contemporary marketplace expectations. Featured Panelists: Scott Snyder, […]
Can Telehealth Accelerate the Uptake of Digital Therapeutics?
Introducing an industry-first, integrated direct-to-patient telehealth solution for digital therapeutics that includes patient engagement, telehealth consultation, prescription issuing and dispensing, and patient support. Fueled by the pandemic, telehealth has moved from an interest to expectation for most patients, with 76% of patients reporting they are comfortable using telehealth. Digital medicine solutions, including digital therapeutics (DTx), have also advanced considerably over the past few years as the value of remote management and non-pharmacological treatment of diseases and chronic conditions has become increasingly apparent to patients, providers, and payers. EVERSANA®, in partnership with UpScript Health, has developed the industry’s first and only patient-led virtual care model leveraging full-scale commercial solutions to accelerate […]
Missed Connection or Meant to Be?
EVERSANA is raising the questions the industry is thinking but is too afraid to ask aloud: Has omnichannel lived up to its promise of the “right message at the right time” to drive meaningful results that wouldn’t otherwise be realized by traditional sales and marketing strategies? Are those “seamless brand experiences” integrating the right mix of digital tools and one-on-one personal engagements accelerating patients’ time to therapy and delivering business impact? Are more prescriptions being written and fulfilled to validate the time, money and resources allocated? Unfortunately, the conclusion is no. The promise of omnichannel activation has fallen short for many pharma manufacturers due to stifling obstacles, coupled with high […]
8 Healthtech Trends For 2023
2023 is here, and with it comes foreshadowing of what the year will bring. In the life sciences and pharmaceutical industry, it’s not different. In fact, many have already made their predictions for the new year, including our experts at EVERSANA INTOUCH, who shared their 7th annual white paper on “Trends That Will Shape Pharma Marketing in 2023” in late November. And as technology continues to evolve at lightning speed across the globe, it’s also changing how healthcare brands interact with physicians, payor and most importantly, patients. Here’s what we see as eight trends that will define 2023. Decentralized Healthcare – Care delivery and health data will continue to move […]
Digital-First Future and the “Data Flywheel”: How Can Pharma Use the Combination of Data, AI, and Content to Drive Successful Product Launches
In this episode of Pharma Launch Secrets, Bozidar Jovicevic, CEO of Evermed, is joined by Scott Snyder, Chief Digital Officer at EVERSANA to discuss: What is the best way to orchestrate personalized digital experiences for HCPs and patients? What is the “data flywheel,” and how can it give pharma companies a competitive advantage? Who is better suited for the digital-first future, large pharma companies or smaller, first-time launchers? Why is starting with the user imperative for the digital-first future? About The Show: “Pharma Launch Secrets” is a podcast by Evermed and hosted by Bozidar Jovicevic, where we host direct, actionable conversations with world-leading pharma launch experts and help you stay […]
Flipping the Script to Disrupt, Redefine and Accelerate the Patient Care Journey
During the COVID-19 pandemic, patients and providers began to recognize the considerable benefits of telehealth services. Patient demand and notable increases in access to care for many have compelled the industry to adopt telehealth as a modern way to treat patients efficiently and effectively. This advancement ushered in more consciousness around the notion that the widespread acceptance that a patient’s treatment journey will likely be a lengthy, stressful and complicated one should no longer be the standard by which we all live. Waiting months to see a specialist, driving long distances to appointments, not knowing if treatments and prescriptions will be covered, and other endless frustrations have long plagued the […]
Reimagining the Patient Care Ecosystem
Improving Access, Removing Barriers and Speeding Up Time to Therapy Patient demand for telehealth and a flood of industry challenges are disrupting the traditional healthcare landscape. Lack of patient awareness, access to care and overburdened clinicians have created significant wait times to see a provider and a prolonged journey to diagnosis and treatment. The lengthy patient journey coupled with the absence of transparent financial processes has increased the need to innovate the care journey. But what if delivery of care was reimagined, making care more accessible and providing greater transparency throughout the process? In this webinar, industry experts Dan Snyder, Chief Marketing Officer at UpScriptHealth; Hiten Chawla, Vice President, Marketing […]
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
By applying transformative commercialization models, nurturing digital transformation and trailblazing in global expansion, we can get therapies to patients around the world who are still waiting for treatment options. For the past two years, the pharmaceutical industry has proven that it can adapt to change. In 2020, pharma pivoted to manage the coronavirus pandemic, and in 2021 the industry was met with the resounding need to keep pushing, keep evolving – so it did. While some change was overdue, such as streamlining outdated processes with leading technologies, other changes were radical and transformative. In the past two years, changing market conditions have forced pharma to consider new strategies, resulting in […]
The Power to Know When: Balancing High-Tech and High-Touch Solutions to Eliminate Access, Affordability and Adherence Barriers
Forty percent of consumers prefer speaking to a real person on the phone, and for more complex issues, 80% want to speak to a live service agent. In the increasingly virtual world we live in, one thing remains clear: we still crave human interactions. As a result, pharma manufacturers need to understand how patients and providers are consuming information, connecting with others, and completing daily tasks. In solving for access, affordability and adherence barriers, they need to adopt a new equation that combines the forces of high-tech and high-touch solutions to: Create a cohesive brand experience, Ensure maximum impact, and Drive therapy adoption. Download the article to discover EVERSANA’s recommended […]
Options and Insights for Successful Development and Launch
Pharma Sponsored Digital Health Solutions and Digital Therapeutics (DTx): Options and Insights for Successful Development and Launch Listen to EVERSANA’s Scott Snyder and Jim O’Donoghue of S3 Connected Health in this recorded webinar as they share insights on the driving forces behind the different types of digital health solutions and #DTx and provide actionable advice on what to consider when developing them.
Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer
Nearly 32% of Americans suffer from complex, chronic or rare conditions, such as autoimmune diseases, genetic disorders or cancer, many of which require a specialty prescription therapy. Despite being only 3% of overall prescriptions, specialty medications represent nearly 50% of the overall prescription drug spend in the U.S. While we have moved to the on-demand economy in most sectors, many steps in the SpecialtyRx journey still require paper, faxes and phone calls. Once receiving a diagnosis and prescription for a complex therapy, many patients are often left to manage their own care, and both doctors and patients are frustrated by the lack of consistent and transparent communication at every stage […]
Disrupting Healthcare from the Inside: How Incumbents Can Lead Change
The following opinion piece was written by Scott Snyder, Chief Digital Officer, for [email protected] Outsider attempts to reinvent healthcare have done little to move the needle despite billions invested in promising concepts like Microsoft’s HealthVault, IBM’s Watson Health, Theranos, Google’s Contact Lens, Drugstore.com, and more recently Helix and Haven. These were backed by some of the most powerful companies and investors in the world, yet they fell significantly short of driving lasting change, and in some cases, as with Theranos and Watson Health, may have set the industry back in breaking through to innovative models for delivering healthcare. So, what happened? Maybe they failed to recognize that the healthcare industry […]